期刊文献+

早幼粒细胞白血病蛋白在髓系白血病细胞中的表达及对细胞增殖的影响 被引量:4

The expression of PML in chronic myeloid leukemia and effect on cell proliferation
原文传递
导出
摘要 目的探讨早幼粒细胞白血病( promyelocyte leukemia, PML)蛋白在髓系白血病中的表达及其对人慢性粒细胞白血病细胞系K562细胞增殖的影响。方法采用实时荧光定量PCR技术检测了30例慢性粒细胞白血病(chronic myeloid leukemia, CML)患者及24名健康对照者外周血单个核细胞中PMLmRNA水平的差异。构建PML的真核表达载体,转染K562细胞后筛选出稳定表达PML的细胞株,以稳定表达空载体的细胞为对照。四甲基偶氮唑盐(MTT)法和流式细胞术分别检测PML过表达对细胞增殖和细胞周期的影响,并进一步用反转录-PCR(RT—PCR)和蛋白质印迹技术(Westernblot)检测增殖相关因子c-myc和p27kip1(p27)mRNA水平以及蛋白表达水平的改变。最后检测了CML患者及健康对照者外周血单个核细胞中c—myc和p27mRNA水平的差异。结果CML患者外周血单个核细胞中PMLmRNA表达水平(△Ct=9.02±0.74)明显低于健康对照组(△Ct=7.91±0.34),差异有统计学意义(t=5.07,P〈0.001)。PML过表达能明显抑制K562细胞增殖,引起细胞周期GO/G1期阻滞。PML稳定表达的K562细胞中,c—myc的mRNA和蛋白表达水平降低,p27的mRNA和蛋白表达水平升高。CML患者外周血单个核细胞中c—myc的mRNA表达水平(△Ct=7.13±0.43)显著高于健康对照组(△Ct=9.35±0.82),差异有统计学意义(t=6.78,P〈0.001),而p27的mRNA表达水平(△Ct=4.56±0.58)则显著低于健康对照组(△Ct=3.29±0.92),差异有统计学意义(t=2.93,P〈0.01)。结论PML在CML患者中低表达,PML可能通过调节c—myc和p27的表达从而抑制白血病细胞的增殖。 Objective To investigate whether PML is expressed differently in chronic myeloid leukemia (CML) patients and healthy controls, then explore the effect of PML on proliferation in leukemia cell lines K562. Methods Real-time PCR was used to detect the PML expression in peripheral blood mononuclear cells from 30 chronic myeloid leukemia patients and 24 healthy controls. Plasmids containing full length PML were constructed and transfected into K562 cell line to screen clones stably expressing PML, the clones stably expressing empty vector as a control. MTT assay and flow cytometry were used to detect the effect of PML on K562 cell proliferation and cell cycle. Furthermore, RT-PCR and western blot were used to detect c-myc and p27kipl (p27) mRNA and protein expression. Lastly, the mRNA levels of c-myc and p27 were detected in CML patients and healthy controls. Results The mRNA level of PML in CML patients (ACt =9.02±0. 74) was significantly lower than the healthy controls ( ACt = 7.91±0. 34) and the difference was statistically significant ( t = 5.07, P 〈 0.001 ) . PML over-expression could inhibit the proliferation of K562 cells obviously and cause GO/G1 cell cycle arrest. In addition, c-myc mRNA and protein expression decreased while p27 mRNA and protein expression increased in K562 cells with stably expressed PML compared with vector control. The mRNA level of c-mye in CML patients (△Ct = 7. 13±0. 43 )was significantly higher than the healthy controls (△Ct = 9. 55±0. 82 )and the difference was statistically significant( t = 6. 78 ,P 〈 0. 001 ), while the mRNA level of p27 in CML patients(△Ct = 4. 56±0. 58)was significantly lower than the healthy controls (△Ct = 3.29± 0. 92 )and the difference was statistically significant( t = 2. 93, P 〈 0. 01 ). Conclusions PML protein is expressed highly in healthy controls, whereas its expression is declined significantly in chronic myeloid leukemia patients. PML may inhibit leukemia cell proliferation through regulating c-myc and p27 expression.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2013年第5期395-399,共5页 Chinese Journal of Laboratory Medicine
关键词 核蛋白质类 转录因子 肿瘤抑制蛋白质类 白血病 髓系 慢性 BCR-ABL阳性 细胞增殖 Nuclear proteins Transcription factors Tumor suppressor proteins Leukemia, myelogenous, chronic, BCR-ABL prositive Cell proliferation
  • 相关文献

参考文献14

  • 1Melnick A, Licht JD. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood, 1999, 93:3167-3215.
  • 2Salomoni P, Pandolfi PP. The role of PML in tumor suppression. Cell, 2002, 108:165-170.
  • 3Dellaire G, Bazett-Jones DP. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays, 2004, 26 : 963-977.
  • 4Trotman LC, Alimonti A, Scaglioni PP, et al. Identification of a turnout suppressor network opposing nuclear Akl function. Nature, 2006. 441:523-527.
  • 5Bernardi R, Guernah I, Jin D, et al. PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR. Nature, 2006, 442:779-785.
  • 6Gurrieri C, Capodieci P, Bernardi R, et al. Loss of the tumor suppressor PML in human cancers of muhiple histologic origins. J Natl Cancer Inst, 2004, 96:269-279.
  • 7Wang ZG, Delva L. Gaboli M, et al. Role of PML in cell growth and the retinoic acid pathway. Seience, 1998, 279:1547-1551.
  • 8Orkin SH, Zon LI. Hematopoiesis:an evolving paradigm for stem cell biology, Cell, 2008, 132:631-644.
  • 9l,oose M, Swiers G, Patient R. Transcriptional networks regulating hematopoietic cell fate decisions. Curr Opin Hematol, 2007, 14:307-314.
  • 10Mu ZM, Le XF, Vallian S, et al. Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. Carcinogenesis, 1997, 18:2063-2069.

二级参考文献10

  • 1HORIGUCHI-YAMADA J,FUKUMI S,SAITO S,et al.DNA topoisomerase Ⅱ inhibitor,etoposide,induces p21WAF1/CIP1 through down-regulation of c-myc in K562cells[J].Anticancer Res,2002,22(6):3827-3832.
  • 2LI K L,CHARLES M R.Antisense technology in molecular and cellular bioengineering [J].Current Opinion in Biotechnology,2003,14:505-511.
  • 3HERRMANN M,LORENZ H M,VOLL R,et al.A rapid and simple method for the isolation of apoptotic DNA fragments[J].Nucleic Acids Res,1994,22:5506-5507.
  • 4XIE S,LIN H,SUN T,et al.Jak2 is involved in c-myc induction by Bcr-Abl[J].Oncogene,2002,21(47):7137-7146.
  • 5PFEIFER A,VERMA I M.Gene Therapy:promises and problems[J].Annu Rev Genomics Hum Genet,2001,2:177-211.
  • 6HEMMINKI A,ALVAREZ R D.Adenoviruses in Oncology.Gene Therapy[J].BioDrugs,2002,16(2):77-87.
  • 7MATSUURA M,YAMAZAKI Y,SUGIYAMA M,et al.Polycation liposome-mediated gene transfer in vivo [J].Biochim Biophys Acta,2003,1612(2):136-143.
  • 8GRZANKA A,SKOK Z,JANIAK A,et al.The expression of proliferating cell nuclear antigen(PCNA) in leukemia cell lines HL-60 and K-562 at the light and electron microscope level[J].Neoplasma,2000,47 (5):288-293.
  • 9DEDOUSSIS G V,ANDRIKOPOULOS N K.Glutathione depletion restores the susceptibility of cisplatin resistant chronic myelogenous leukemia cell lines to natural killer cell-mediated cell death via necrosis rather than apoptosis[J].Eur J Cell Biol,2001,80(9):608-614.
  • 10张敬,张军,赵燕,石红军,蔡梅雪.硒和维生素E对白血病细胞凋亡及c-Myc基因表达的影响[J].营养学报,2001,23(4):324-326. 被引量:13

共引文献3

同被引文献34

  • 1Fang B Zheng C Liao L Han Q Sun Z Jiang X Zhao RC.Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics[J].中国生物学文摘,2006,20(5):16-17. 被引量:3
  • 2Kim TH1, Abdullaev ZK, Smith AD, et al. Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome [J]. Cell, 2007, 128:1231-1245.
  • 3Merkenschlager M, Odom DT. CTCF and cohesin: linking gene regulatory elements with their targets [ J ]. Cell, 2013, 152-1285-1297.
  • 4Ong CT, Corces VG. CTCF: an architectural protein bridg- ing genome topology and function [ J ]. Nat Rev Genet, 2014, 15:234-246.
  • 5Fiorentino FP, Giordano A. The tumor suppressor role of CTCF [J]. J Cell Physiol. 2012. 227.479-492.
  • 6Cleton-Jansen AM. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? [ J ]. Breast Cancer Res, 2002, 4:5-8.
  • 7Green, AR, Krivinskas S, et al. Loss of expression of chro- mosome 16q genes DPEP1 and CTCF in lobular carcinomain sitn of the breast [ J ]. Breast Cancer Res Treat, 2009, If3: 59-66.
  • 8Tiffen JC, Bailey CG, Marshall AD, et aL The cancer-tes- tis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic ceils [J]. Int J Cancer, 2013, 133 : 1603-1613.
  • 9Yoshida K, Toki T, Okuno Y, et al. The landscape of so- matic mutations in Down syndrome-related myeloid disor- ders [J]. Nat Genet, 2013, 45:1293-1299.
  • 10Marshall AD, Bailey CG, Rasko JE. CTCF and BORIS in genome regulation and cancer. [ J ]. Curt Opin Genet Dev, 2014, 24:8-15.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部